SYDNEY, AUSTRALIA, April 22, 2026 (GLOBE NEWSWIRE)-- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage immunotherapy company targeting cancer and autoimmune ...

Rosewood Arts Center has opened two solo exhibitions, an immersive sculptural installation by Nathan Foley, and paintings and ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that an abstract highlighting data on ...

Oregon hasn't developed a high school QB into a starter since Justin Herbert. With Dylan Raiola ahead of Will Mencl and the ...

From air traffic controllers to elevator mechanics, these well-paying jobs sit chronically understaffed. Here's the salary ...

Matsui declined requests by The Bee to meet with Vang and the Editorial Board (all our endorsement meetings with candidates — ...

Monthly homeschool art classes at Anniston library offer hands-on learning in drawing, painting and crafts for students ages 5-18. — Youth services leaders blend art history with ...

Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules targeting RNA and RNA regulation ...

ADCE-T02, a potential best-in-class Tissue Factor targeted antibody-drug conjugate (ADC), enters cohort expansion portion of the Tiffany-01 study in advanced solid tumors; Two ADC ...

The talent is here. The capital is arriving. So why does Europe keep losing? The answer isn’t regulation, though the reflex ...

Natural today announced that CLI has joined the company as Chief Compliance and Regulatory Officer. CLI brings deep experience in payments compliance and regulation. She was the first regulatory hire ...

(“Immunome”) (Nasdaq: IMNM), a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies, today announced that data from RINGSIDE, its global, Phase 3, ...